199 related articles for article (PubMed ID: 25158305)
1. Sodium butyrate, a HDAC inhibitor ameliorates eNOS, iNOS and TGF-β1-induced fibrogenesis, apoptosis and DNA damage in the kidney of juvenile diabetic rats.
Khan S; Jena G
Food Chem Toxicol; 2014 Nov; 73():127-39. PubMed ID: 25158305
[TBL] [Abstract][Full Text] [Related]
2. Sodium valproate ameliorates diabetes-induced fibrosis and renal damage by the inhibition of histone deacetylases in diabetic rat.
Khan S; Jena G; Tikoo K
Exp Mol Pathol; 2015 Apr; 98(2):230-9. PubMed ID: 25576297
[TBL] [Abstract][Full Text] [Related]
3. Protective role of sodium butyrate, a HDAC inhibitor on beta-cell proliferation, function and glucose homeostasis through modulation of p38/ERK MAPK and apoptotic pathways: study in juvenile diabetic rat.
Khan S; Jena GB
Chem Biol Interact; 2014 Apr; 213():1-12. PubMed ID: 24530320
[TBL] [Abstract][Full Text] [Related]
4. Histone deacetylase-2 is a key regulator of diabetes- and transforming growth factor-beta1-induced renal injury.
Noh H; Oh EY; Seo JY; Yu MR; Kim YO; Ha H; Lee HB
Am J Physiol Renal Physiol; 2009 Sep; 297(3):F729-39. PubMed ID: 19553350
[TBL] [Abstract][Full Text] [Related]
5. Valproate attenuates the proteinuria, podocyte and renal injury by facilitating autophagy and inactivation of NF-κB/iNOS signaling in diabetic rat.
Khan S; Jena G; Tikoo K; Kumar V
Biochimie; 2015 Mar; 110():1-16. PubMed ID: 25572918
[TBL] [Abstract][Full Text] [Related]
6. Sodium butyrate activates NRF2 to ameliorate diabetic nephropathy possibly via inhibition of HDAC.
Dong W; Jia Y; Liu X; Zhang H; Li T; Huang W; Chen X; Wang F; Sun W; Wu H
J Endocrinol; 2017 Jan; 232(1):71-83. PubMed ID: 27799462
[TBL] [Abstract][Full Text] [Related]
7. Selective phosphodiesterase-5 (PDE-5) inhibitor vardenafil ameliorates renal damage in type 1 diabetic rats by restoring cyclic 3',5' guanosine monophosphate (cGMP) level in podocytes.
Fang L; Radovits T; Szabó G; Mózes MM; Rosivall L; Kökény G
Nephrol Dial Transplant; 2013 Jul; 28(7):1751-61. PubMed ID: 23203993
[TBL] [Abstract][Full Text] [Related]
8. Sodium butyrate ameliorates erectile dysfunction through fibrosis in a rat model of partial bladder outlet obstruction.
Kaya-Sezginer E; Yilmaz-Oral D; Kırlangıç OF; Yilmaz S; Özen FZ; Aşan M; Gur S
Andrology; 2022 Oct; 10(7):1441-1453. PubMed ID: 35852413
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of apoptosis and modulation of TGF-β1 by sodium selenate prevents streptozotocin-induced diabetic rat renal impairment.
Roy S; Dontamalla SK; Mondru AK; Sannigrahi S; Veerareddy PR
Biol Trace Elem Res; 2011 Jan; 139(1):55-71. PubMed ID: 20174975
[TBL] [Abstract][Full Text] [Related]
10. Astragaloside IV protects against diabetic nephropathy via activating eNOS in streptozotocin diabetes-induced rats.
Fan Y; Fan H; Zhu B; Zhou Y; Liu Q; Li P
BMC Complement Altern Med; 2019 Dec; 19(1):355. PubMed ID: 31805910
[TBL] [Abstract][Full Text] [Related]
11. Histone deacetylase (HDAC) inhibition improves myocardial function and prevents cardiac remodeling in diabetic mice.
Chen Y; Du J; Zhao YT; Zhang L; Lv G; Zhuang S; Qin G; Zhao TC
Cardiovasc Diabetol; 2015 Aug; 14():99. PubMed ID: 26245924
[TBL] [Abstract][Full Text] [Related]
12. Liraglutide ameliorates renal injury in streptozotocin‑induced diabetic rats by activating endothelial nitric oxide synthase activity via the downregulation of the nuclear factor‑κB pathway.
Zhou SJ; Bai L; Lv L; Chen R; Li CJ; Liu XY; Yu DM; Yu P
Mol Med Rep; 2014 Nov; 10(5):2587-94. PubMed ID: 25215431
[TBL] [Abstract][Full Text] [Related]
13. The histone deacetylase inhibitor sodium butyrate decreases excessive ethanol intake in dependent animals.
Simon-O'Brien E; Alaux-Cantin S; Warnault V; Buttolo R; Naassila M; Vilpoux C
Addict Biol; 2015 Jul; 20(4):676-89. PubMed ID: 25041570
[TBL] [Abstract][Full Text] [Related]
14. Arsenic toxicity induced endothelial dysfunction and dementia: pharmacological interdiction by histone deacetylase and inducible nitric oxide synthase inhibitors.
Sharma B; Sharma PM
Toxicol Appl Pharmacol; 2013 Nov; 273(1):180-8. PubMed ID: 23921152
[TBL] [Abstract][Full Text] [Related]
15. Valproic Acid Improves Glucose Homeostasis by Increasing Beta-Cell Proliferation, Function, and Reducing its Apoptosis through HDAC Inhibition in Juvenile Diabetic Rat.
Khan S; Jena G
J Biochem Mol Toxicol; 2016 Sep; 30(9):438-46. PubMed ID: 27079868
[TBL] [Abstract][Full Text] [Related]
16. Ultrastructure characterization of pancreatic β-cells is accompanied by modulatory effects of the HDAC inhibitor sodium butyrate on the PI3/AKT insulin signaling pathway in juvenile diabetic rats.
Elgamal DA; Abou-Elghait AT; Ali AY; Ali M; Bakr MH
Mol Cell Endocrinol; 2020 Mar; 503():110700. PubMed ID: 31904405
[TBL] [Abstract][Full Text] [Related]
17. Protective effects of enalapril in streptozotocin-induced diabetic rat: studies of DNA damage, apoptosis and expression of CCN2 in the heart, kidney and liver.
Kushwaha S; Vikram A; Jena GB
J Appl Toxicol; 2012 Sep; 32(9):662-72. PubMed ID: 21416479
[TBL] [Abstract][Full Text] [Related]
18. Sodium butyrate mitigates type 2 diabetes by inhibiting PERK-CHOP pathway of endoplasmic reticulum stress.
Hu Y; Liu J; Yuan Y; Chen J; Cheng S; Wang H; Xu Y
Environ Toxicol Pharmacol; 2018 Dec; 64():112-121. PubMed ID: 30342372
[TBL] [Abstract][Full Text] [Related]
19. Rescue of mesangial cells from high glucose-induced over-proliferation and extracellular matrix secretion by hydrogen sulfide.
Yuan P; Xue H; Zhou L; Qu L; Li C; Wang Z; Ni J; Yu C; Yao T; Huang Y; Wang R; Lu L
Nephrol Dial Transplant; 2011 Jul; 26(7):2119-26. PubMed ID: 21208996
[TBL] [Abstract][Full Text] [Related]
20. Esculetin induced changes in Mmp13 and Bmp6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats.
Surse VM; Gupta J; Tikoo K
J Mol Endocrinol; 2011 Jun; 46(3):245-54. PubMed ID: 21450970
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
